Clinical Trials Logo

Clinical Trial Summary

Maturity level of dendritic cells (DC) plays a pivotal role in initiating and regulating autoimmunity. In Graves' disease (GD), DCs have more active immune responses than those in healthy subjects. Our previous study demonstrated immunoregulatory effects of in vitro 1,25-D3 on maturation of DC in GD patients. This study aims to evaluate the effect of oral 1α-D3 on DC maturation in GD patients.


Clinical Trial Description

Patients with Graves' disease were divided into two groups: groups receiving oral 1α-D3 in addition to propylthiouracil (PTU) and groups receiving placebos in addition to PTU. Comparison of DC maturation were performed before and after the oral 1α-D3. DC maturation was assessed based on the expression of DC markers (HLA-DR, CD80, CD40, CD83, CD14 and CD206) and the ratio of cytokines interleukin-12/IL-10. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02993302
Study type Interventional
Source Dr Cipto Mangunkusumo General Hospital
Contact
Status Completed
Phase Phase 2
Start date July 2014
Completion date March 2015

See also
  Status Clinical Trial Phase
Completed NCT02973802 - ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy Phase 1
Completed NCT02491567 - DNA Methylation and Autoimmune Thyroid Diseases
Terminated NCT01320813 - Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy N/A
Completed NCT00432146 - Effect of Lugol's Solution in the Patients With Graves' Disease N/A
Completed NCT01727973 - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy Phase 1/Phase 2
Active, not recruiting NCT04135573 - The Relationship Between NK Cell and Graves' Disease
Completed NCT03009357 - Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
Recruiting NCT03303053 - Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism Phase 3
Not yet recruiting NCT04239521 - The Epidemiology, Management, and the Associated Burden of Mental Health, Atopic and Autoimmune Conditions in Alopecia Areata
Completed NCT00782366 - Predictive Genetic Risk Assessment Trial N/A
Enrolling by invitation NCT04789993 - Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up
Recruiting NCT03066076 - Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy Phase 3
Recruiting NCT04932135 - Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism
Completed NCT02376088 - Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease N/A
Completed NCT01227499 - Differential Diagnosis of STA-PSV in Thyrotoxicosis N/A
Completed NCT03498417 - Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy
Recruiting NCT02203682 - Doxycycline Treatment in Mild Graves' Orbitopathy Phase 2
Completed NCT00677469 - Low Doses of Cholestyramine in the Treatment of Hyperthyroidism N/A
Completed NCT00796913 - Remission Induction and Sustenance in Graves' Disease 2 N/A
Completed NCT00150137 - Antithyroid Drugs During Radioiodine Therapy Phase 4